ALPHA TAU MEDICAL LTD

Levy Raphi’s recent round‑trip trade at Alpha Tau Medical shows a CFO buying low at $2.98 and selling near $14, hinting at a strategic bet on upcoming clinical milestones and potential upside.

Alpha Tau Medical CFO’s bold insider buy at $2.98 signals confidence amid a 23% weekly jump, hinting at upside for oncology device investors.

Alpha Tau Medical CFO sells 20k shares: insider trend, market impact, and what it means for investors.

Insider sales surge at Alpha Tau amid a 25% rally—CFO Levy Raphi sells 20,000 shares at $12.00. Explore how this impacts valuation, dilution, and future growth.

Alpha Tau Medical CFO sells 20k shares amid 258% YTD rally – what insider moves mean for investors and the company’s oncology‑device future.

Alpha Tau Medical CFO sells shares after clinical win—find out how insider trades signal a bullish outlook and buying opportunities near $10.

Alpha Tau Medical CFO sells shares amid 242% YoY surge; insider move seen as routine liquidity, not a red flag, as partnership with Tolmar drives growth hopes.

Alpha Tau Medical insider stakes grow as executives back the firm’s alpha‑radiation therapy, signaling confidence before key clinical milestones.